RMBS Stock Analysis: Rambus | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 10.906m USD | 12M Return: 56.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 349M
EPS Trend: 7.0%
Qual. Beats: 0
Rev. Trend: 96.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Rambus Inc. (NASDAQ: RMBS) is a U.S.-headquartered semiconductor company founded in 1990 and based in San Jose, California, operating within the Information Technology sector. The company generates revenue from two primary lines: the sale of memory interface chips (most notably DDR5 and DDR4 components such as registering clock drivers, data buffers, and power management ICs) and the licensing of silicon intellectual property covering high-speed interface and security solutions. It also monetizes a historical portfolio of patents covering memory architecture, high-speed serial links, and security technology.
Rambus sells to memory module manufacturers, OEMs, hyperscalers, and chip makers, using both a direct sales force and third-party distributors across the United States, South Korea, Singapore, and other international markets. Within the broader semiconductor industry, Rambus occupies a niche as a fabless supplier of interface and security silicon IP rather than a competing manufacturer of memory or logic devices, a business model that allows it to capture royalty and per-chip licensing revenue tied to the adoption of advanced memory standards like DDR5 in data center, AI, and automotive applications.
- DDR5 memory interface chip revenue ramps on hyperscaler demand
- Silicon IP licensing expands with AI data center adoption
- Patent royalty stream pressured by memory maker renegotiations
| Net Income: 230.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 4.95 > 1.0 |
| NWC/Revenue: 124.5% < 20% (prev 107.1%; Δ 17.40% < -1%) |
| CFO/TA 0.24 > 3% & CFO 365.8m > Net Income 230.0m |
| Net Debt (-762.7m) to EBITDA (318.1m): -2.40 < 3 |
| Current Ratio: 9.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (109.7m) vs 12m ago 1.00% < -2% |
| Gross Margin: 77.03% > 18% (prev 75.87%; Δ 1.16% > 0.5%) |
| Asset Turnover: 49.52% > 50% (prev 43.89%; Δ 5.63% > 0%) |
| Interest Coverage Ratio: 222.9 > 6 (EBIT TTM 284.2m / Interest Expense TTM 1.27m) |
| A: 0.59 (Total Current Assets 999.9m - Total Current Liabilities 101.8m) / Total Assets 1.53b |
| B: 0.09 (Retained Earnings 136.7m / Total Assets 1.53b) |
| C: 0.20 (EBIT TTM 284.2m / Avg Total Assets 1.46b) |
| D: 9.96 (Book Value of Equity 1.39b / Total Liabilities 139.9m) |
| Altman-Z'' = 15.90 = AAA |
| DSRI: 0.79 (Receivables 134.2m/142.8m, Revenue 721.2m/605.4m) |
| GMI: 0.98 (GM 75.87% / 77.03%) |
| AQI: 0.68 (AQ_t 0.27 / AQ_t-1 0.40) |
| SGI: 1.19 (Revenue 721.2m / 605.4m) |
| TATA: -0.09 (NI 230.0m - CFO 365.8m) / TA 1.53b) |
| Beneish M = -3.28 (Cap -4..+1) = AA |
As of July 24, 2026, the stock is trading at USD 103.19 with a total of 1,743,110 shares traded. Over the past week, the price has changed by +1.75%, over one month by -19.51%, over three months by -25.49% and over the past year by +56.47%.
Current recommended Stop Loss: 84.40 (which is 18.2% or 2 ATR below the current price).
Rambus has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy RMBS.
- StrongBuy: 7
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 149 | 44.4% |
P/E Trailing = 48.2536
P/E Forward = 24.1546
P/S = 15.1224
P/B = 7.8562
P/EG = 3.8007
Revenue TTM = 721.2m USD
EBIT TTM = 284.2m USD
EBITDA TTM = 318.1m USD
Long Term Debt = 17.0m USD (estimated: total debt 23.4m - short term 6.36m)
Short Term Debt = 6.36m USD (from shortTermDebt, last quarter)
Debt = 23.4m USD (from shortLongTermDebtTotal, last quarter) (leases 23.4m already included)
Net Debt = -762.7m USD (calculated: Debt 23.4m - CCE 786.1m)
Enterprise Value = 10.1b USD (10.9b + Debt 23.4m - CCE 786.1m)
Interest Coverage Ratio = 222.9 (Ebit TTM 284.2m / Interest Expense TTM 1.27m)
EV/FCF = 30.26x (Enterprise Value 10.1b / FCF TTM 335.2m)
FCF Yield = 3.30% (FCF TTM 335.2m / Enterprise Value 10.1b)
FCF Margin = 46.48% (FCF TTM 335.2m / Revenue TTM 721.2m)
Net Margin = 31.89% (Net Income TTM 230.0m / Revenue TTM 721.2m)
Gross Margin = 77.03% ((Revenue TTM 721.2m - Cost of Revenue TTM 165.6m) / Revenue TTM)
Gross Margin QoQ = 79.73% (prev 78.86%)
Tobins Q-Ratio = 6.62 (Enterprise Value 10.1b / Total Assets 1.53b)
Interest Expense / Debt = 5.45% (Interest Expense 1.27m / Debt 23.4m)
Taxrate = 18.71% (53.0m / 283.0m)
NOPAT = 231.0m (EBIT 284.2m * (1 - 18.71%))
Current Ratio = 9.82 (Total Current Assets 999.9m / Total Current Liabilities 101.8m)
Debt / Equity = 0.02 (Debt 23.4m / totalStockholderEquity, last quarter 1.39b)
Debt / EBITDA = -2.40 (Net Debt -762.7m / EBITDA 318.1m)
Debt / FCF = -2.28 (Net Debt -762.7m / FCF TTM 335.2m)
Total Stockholder Equity = 1.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.79% (Net Income 230.0m / Total Assets 1.53b)
RoE = 17.44% (Net Income TTM 230.0m / Total Stockholder Equity 1.32b)
RoCE = 21.28% (EBIT 284.2m / Capital Employed (Equity 1.32b + L.T.Debt 17.0m))
RoIC = 16.48% (NOPAT 231.0m / Invested Capital 1.40b)
WACC = 15.98% (E(10.9b)/V(10.9b) * Re(16.0%) + D(23.4m)/V(10.9b) * Rd(5.45%) * (1-Tc(0.19)))
Discount Rate = 16.0% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -17.32 | Cagr: -0.14%
[DCF] Terminal Value 57.23% ; FCFF base≈294.5m ; Y1≈337.5m ; Y5≈496.8m
[DCF] Fair Price = 36.16 (EV 3.15b - Net Debt -762.7m = Equity 3.91b / Shares 108.1m; r=15.98% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 7.02 | EPS CAGR: 1.35% | SUE: -0.16 | # QB: 0
Revenue Correlation: 96.42 | Revenue CAGR: 21.17% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.71 | Chg30d=-0.69% | Revisions=+25% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.78 | Chg30d=+0.49% | Revisions=+25% | Analysts=8
EPS current Year (2026-12-31): EPS=2.94 | Chg30d=-0.07% | Revisions=+25% | GrowthEPS=+19.8% | GrowthRev=+16.0%
EPS next Year (2027-12-31): EPS=3.66 | Chg30d=+0.39% | Revisions=+40% | GrowthEPS=+24.6% | GrowthRev=+20.2%
[Analyst] Revisions Ratio: +62% (up=5, down=0)